Loading…
IXICO is a global leader in neuroimaging and biomarker analytics, providing precision imaging biomarker insights for neurological disease research. Its proprietary IXI™ platform uses AI to manage clinical trial data, read radiological scans, and measure key biomarkers for conditions like Alzheimer’s, Huntington’s, and Parkinson’s disease.
AI named IXICO from February 2026 to March 2026.